These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6595096)

  • 1. Urinary prostaglandins in sickle cell nephropathy: a defect in 9-ketoreductase activity?
    de Jong PE; Saleh AW; de Zeeuw D; Donker AJ; van der Hem GK; Pratt JJ; Sewrajsingh GS; Statius van Eps LW
    Clin Nephrol; 1984 Oct; 22(4):212-3. PubMed ID: 6595096
    [No Abstract]   [Full Text] [Related]  

  • 2. [Is the enzyme PGE2-9-ketoreductase of significance in the pathogenesis of essential hypertension?].
    Rathaus M; Korzets Z; Bernheim J
    Harefuah; 1982 Sep; 103(5-6):96-7. PubMed ID: 6963241
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolism of prostaglandins by human renal enzymes: presence of 9-hydroxyprostaglandin dehydrogenase activity in human kidney.
    Hassid A; Sebrosky A; Dunn MJ
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():499-504. PubMed ID: 6221570
    [No Abstract]   [Full Text] [Related]  

  • 4. Dexamethasone effect on renal prostaglandin-9-ketoreductase activity in the rabbit.
    Naray-Fejes-Toth A; Fejes-Toth G
    Prostaglandins Leukot Med; 1985 Aug; 19(2):133-7. PubMed ID: 3863150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal PGs in essential hypertension; the role of water-electrolyte shifts in their metabolism.
    Nekrasova AA; Levitskaya YuV
    Biomed Biochim Acta; 1984; 43(8-9):S251-4. PubMed ID: 6596098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of prostaglandins and renin in sickle-cell nephropathy. A hypothesis.
    de Jong PE; de Jong-van den Berg LT; Donker AJ; Statius van Eps LW
    Neth J Med; 1978; 21(2):67-72. PubMed ID: 26030
    [No Abstract]   [Full Text] [Related]  

  • 7. Characterization of two enzyme proteins catalyzing NADP+/NADPH-dependent oxidoreduction of prostaglandins at C-9 and C-15 from swine kidney.
    Chang DG; Tai HH
    Arch Biochem Biophys; 1982 Apr; 214(2):464-74. PubMed ID: 6807198
    [No Abstract]   [Full Text] [Related]  

  • 8. Enriched prostaglandin E-9 ketoreductase activity in outer medullary cells of the rabbit kidney.
    Miller MJ; Carroll MA; Schwartzman M; Ferreri NR; McGiff JC
    Prostaglandins; 1985 Nov; 30(5):867-77. PubMed ID: 3866264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin E2-9-ketoreductase as a mediator of salt intake-related prostaglandin-renin interaction.
    Weber PC; Larsson C; Scherer B
    Nature; 1977 Mar; 266(5597):64-6. PubMed ID: 840299
    [No Abstract]   [Full Text] [Related]  

  • 10. Urinary excretion of prostaglandins E2 and F2 alpha in rats with hereditary diabetes insipidus.
    Rathaus M; Kariv N; Shapira J; Bernheim J
    Isr J Med Sci; 1984 Aug; 20(8):722-4. PubMed ID: 6590536
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of postpartal atony with prostaglandins].
    Heinzl S; Hendry M
    Z Geburtshilfe Perinatol; 1986; 190(2):92-4. PubMed ID: 3459314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary prostaglandin E2 in chronic renal disease.
    Ruilope L; Bernis C; Garcia-Robles R; Alcazar J; Barrientos A; Tresguerres JA; Rodicio J
    Clin Nephrol; 1981 Oct; 16(4):215. PubMed ID: 6945927
    [No Abstract]   [Full Text] [Related]  

  • 13. Renal prostaglandins in pre-eclampsia.
    Rathaus M; Kovatz S; Ben Aderet N; Bernheim J
    Clin Nephrol; 1982 Oct; 18(4):216. PubMed ID: 6958402
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of tritiated prostaglandins in metabolism studies. II: Kinetic isotope effect: an useful tool to investigate catabolizing sequence of prostaglandins.
    Moussard C; Alber D; Perruche C; Henry JC
    Prostaglandins; 1986 Mar; 31(3):501-8. PubMed ID: 3459214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes in urinary prostaglandin excretion in hypertension patients undergoing variants of furosemide administration].
    Dzhusipov AK; Nekrasova AA
    Ter Arkh; 1984; 56(4):90-4. PubMed ID: 6587605
    [No Abstract]   [Full Text] [Related]  

  • 16. Renal prostaglandins in borderline and sustained essential hypertension.
    Lebel M; Grose JH
    Prostaglandins Leukot Med; 1982 May; 8(5):409-18. PubMed ID: 7048332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on 15-hydroxyprostaglandin dehydrogenase from monkey lung.
    Sun FF; Armour SB; Bockstanz VR; McGuire JC
    Adv Prostaglandin Thromboxane Res; 1976; 1():163-9. PubMed ID: 826140
    [No Abstract]   [Full Text] [Related]  

  • 18. Renal prostaglandins E2 and F2 alpha in normal pregnancy and in pregnancy with hypertension.
    Kovatz S; Rathaus M; Aderet NB; Bernheim J
    Proc Eur Dial Transplant Assoc; 1981; 18():512-6. PubMed ID: 6949162
    [No Abstract]   [Full Text] [Related]  

  • 19. Urinary excretion of prostaglandins and thromboxanes in the hepatorenal syndrome.
    Kronborg IJ; Radvan G; Zipser RD
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():539-42. PubMed ID: 6221576
    [No Abstract]   [Full Text] [Related]  

  • 20. Decreased renal prostaglandin E2 metabolism: a mechanism for the regulation of prostaglandin activity in acute renal failure.
    Chaudhari A; Kirschenbaum MA
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():543-6. PubMed ID: 6221577
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.